Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience

doi:10.5500/wjt.v6.i2.396

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6138)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

442

WORD

258

HTML

2677

Figures (1-2)

128

Tables (1-3)

152

Sum=3657

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1125

Download

1356

Sum=2481

Jun 24, 2016 (publication date) through Jul 11, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Transplant. Jun 24, 2016; 6(2): 396-402
Published online Jun 24, 2016. doi: 10.5500/wjt.v6.i2.396

Full Size Figure Download Figure

Figure 1 Kaplan-Meier estimates of overall survival (A and B) and recurrence free survival (C and D) in relation to compliance with the Milan and University of California San Francisco criteria. UCSF: University of California San Francisco.

Citation: O’Connor DB, Burke JP, Hegarty J, McCormick AP, Nolan N, Hoti E, Maguire D, Geoghegan J, Traynor O. Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience. World J Transplant 2016; 6(2): 396-402
URL: https://www.wjgnet.com/2220-3230/full/v6/i2/396.htm
DOI: https://dx.doi.org/10.5500/wjt.v6.i2.396